PLUS1
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 64.99 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| uniQure NV | QURE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.99 | 3.16% | 64.99 | 65.57 | 63.00 | 63.10 | 63.00 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 61.25 | 84.65 | 23.40 | 27.64% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,372 | 1,024,938 | $ 64.55 | $ 66,162,435 | 548,811 | 24.07 - 82.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:28:33 | formt | 59,544 | $ 64.99 | USD |
uniQure NV Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.83B | 43.62M | $ -83.30M | -2.34 | - | 42.51M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 5.00 | 3.50% |
uniQure NV News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/09/2019 | 18:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/08/2019 | 16:00 | GlobeNewswire Inc. | uniQure Announces One-Year Follow-Up Data from the Phase IIb.. |
| 12/02/2019 | 07:00 | GlobeNewswire Inc. | uniQure to Participate in Multiple Upcoming Industry.. |
| 11/22/2019 | 10:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/19/2019 | 08:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/06/2019 | 09:16 | GlobeNewswire Inc. | uniQure Announces Clinical Data Presentations at the 61st.. |
| 11/05/2019 | 17:27 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QURE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 64.00 | 70.00 | 61.00 | 64.25 | 1,201,033 | 0.99 | 1.55% |
| 1 Month | 53.79 | 70.00 | 50.41 | 59.70 | 569,891 | 11.20 | 20.82% |
| 3 Months | 46.90 | 70.00 | 36.20 | 49.90 | 527,487 | 18.09 | 38.57% |
| 6 Months | 75.31 | 82.49 | 36.20 | 59.12 | 628,752 | -10.32 | -13.7% |
| 1 Year | 30.03 | 82.49 | 24.07 | 56.40 | 565,044 | 34.96 | 116.42% |
| 3 Years | 6.03 | 82.49 | 4.72 | 37.28 | 414,140 | 58.96 | 977.78% |
| 5 Years | 16.00 | 82.49 | 4.72 | 31.04 | 366,094 | 48.99 | 306.19% |
uniQure NV Description
| uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophilia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in Lexington Massachusetts and research and development facility in Amsterdam, the Netherlands, and Heidelberg, Germany. It is focused on the development of pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases. |
